GPNMB, LRRK2, and lysosome exocytosis in Parkinson’s
Science Advances · 2025
DOI: 10.1126/sciadv.aed8002 ↗At a glance
Übersichtsarbeit in Science Advances, 2025. Written by Suzanne R Pfeffer. Institution: Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307, USA and Aligning Science Across Parkinson's, Chevy Chase…. Major MEDLINE topics: Lysosomes, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Exocytosis. 11 references. The full text is freely available in PubMed Central.
Abstract (original language)
When two genes linked to increased Parkinson’s risk converge on a lysosome, LRRK2 mutation enhances lysosomal release of soluble GPNMB potentially contributing to synuclein pathology.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307, USA and Aligning Science Across Parkinson's, Chevy Chase, MD 20815 USA.
ORCID profiles: Suzanne R Pfeffer
Cite
APA
Pfeffer, S. R. (2025). GPNMB, LRRK2, and lysosome exocytosis in Parkinson’s. Science Advances. https://doi.org/10.1126/sciadv.aed8002
Vancouver
Pfeffer SR. GPNMB, LRRK2, and lysosome exocytosis in Parkinson’s. Science Advances. 2025. doi:10.1126/sciadv.aed8002
BibTeX
@article{Pfeffer2025,
author = {Pfeffer, Suzanne R},
title = {GPNMB, LRRK2, and lysosome exocytosis in Parkinson’s},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.aed8002}
}
EUVIMED